Standigm and Protai Launch Joint R&D Program to Design Selective Molecular Glue Degraders Using Structural Proteomics and Generative AI
<p>Korea-Israel collaboration, supported by KORIL-RDF, pairs Protai's AI-powered structural proteomics with Standigm's generative drug design to tackle selectivity - a central challenge in targeted protein degradation SEOUL, Republic of Korea and TEL AVIV, Israel, Sept. 16, 2026 /PRNewswire/...</p>
Read original article ↗
Related Articles
A new interpretation of Homer's "The Odyssey" that will intrigue audiences who enjoyed Nolan's "The Odyssey", and fascin
Former Cox Customers Now Have Access to Spectrum's Products, Packaging and Pricing Key Takeaways: Spectrum Day introduce
Organizations can use D&B's verified information on business identity, relationships, and risk to power AI agents across
Backed By Andreessen Horowitz (a16z) and Index Ventures, Ferry Automates Healthcare Tasks for Patients, Starting with Fi